Why the study?
Marantic endocarditis associated with the hypercoagulable state of COVID-19 is rarely reported, and this case was presented to raise physician awareness of this potential association.
Case Report (n=1)
No
Therapeutic anticoagulation successfully resolved marantic endocarditis and left ventricular thrombus in a patient with COVID-19-associated hypercoagulability.
Answers are grounded in this paper and cite their sources.
NBTE may complicate COVID-19 hypercoagulability; single case leaves open incidence and need for prospective evaluation.
Coronavirus disease 2019 (COVID-19) has overwhelmed healthcare globally with millions of cases and over 2 million deaths worldwide. The hypercoagulable state associated with COVID-19 is a well-recognized complication that carries a poor prognosis. Marantic endocarditis, or non-bacterial thrombotic endocarditis (NBTE), is caused by a sterile vegetation on the cardiac valves resulting from the deposition of fibrin and platelet aggregates. It is highly associated with the hypercoagulable and acquired inflammatory states. Herein, we report a unique and rare case of COVID-19 presenting with NBTE. LEARNING POINTS: COVID-19 has caused a major global pandemic, with high morbidity and mortality.One of the complications of COVID-19 infection is a hypercoagulable state.To the best of our knowledge, we present only the second case of marantic endocarditis in a patient with COVID-19, in the hope of raising awareness among physicians of this potential rare association.
No takes yet. Share an insight, caveat, or question.
Chan et al. (2021) conducted a case report in Marantic endocarditis (NBTE) associated with COVID-19 (n=1). Therapeutic anticoagulation (enoxaparin and apixaban) was evaluated on Resolution of vegetation and left ventricle thrombus.
Synapse has enriched 10 related papers. Consider them for comparative context: